| 公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
| 2011 | Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation | Laport, G. G.; Sheehan, K.; Baker, J.; Armstrong, R.; Wong, R. M.; Lowsky, R.; Johnston, L. J.; Shizuru, J. A.; Miklos, D.; Arai, S.; Benjamin, J. E.; Wen-Kai Weng ; Negrin, R. S. | Biology of Blood and Marrow Transplantation | | | |
| 2015 | Allogeneic hematopoietic cell transplant for normal karyotype AML: indirect evidence of selection for adverse molecular profile | Percival, M. E. M.; Medeiros, B. C.; Tian, L.; Robeson, S.; Laport, G. G.; Johnston, L. J.; Shizuru, J. A.; Miklos, D. B.; Arai, S.; Wen-Kai Weng ; Negrin, R. S.; Lowsky, R. | Bone Marrow Transplantation | | | |
| 2015 | Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning | Rezvani, A. R.; Kanate, A. S.; Efron, B.; Chhabra, S.; Kohrt, H. E.; Shizuru, J. A.; Laport, G. G.; Miklos, D. B.; Benjamin, J. E.; Johnston, L. J.; Arai, S.; Wen-Kai Weng ; Negrin, R. S.; Strober, S.; Lowsky, R. | Bone Marrow Transplantation | | | |
| 2020 | Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Significant Increase in Survival in the Post-Targeted Immunotherapy Era | Muffly, L.; Arai, S.; Johnston, L.; Lowsky, R.; Meyer, E. H.; Miklos, D. B.; Negrin, R. S.; Rezvani, A.; Shiraz, P.; Shizuru, J. A.; Sidana, S.; Wen-Kai Weng ; Cunanan, K. | Biology of Blood and Marrow Transplantation | | | |
| 2016 | Allogeneic Transplants from HLA-Mismatched Unrelated Donors Using Total Lymphoid Irradiation and Antithymocyte Globulin Conditioning Retain a Low Risk of Graft-Versus-Host Disease and Non-Relapse Mortality with at Least As Potent Anti-Tumor Activity As with Matched Unrelated Donors | Spinner, M. A.; Vina, M. F.; Elder, L.; Arai, S.; Johnston, L.; Meyer, E.; Miklos, D.; Muffly, L.; Negrin, R. S.; Shizuru, J.; Wen-Kai Weng ; Laport, G. G.; Strober, S.; Lowsky, R.; Rezvani, A. R. | Blood | | | |
| 2007 | Autologous cytokine-induced killer cells as post-transplant cellular immunotherapy | Arai, S.; Sheehan, K.; Moore, S.; Laport, G.; Johnston, L.; Lowsky, R.; Miklos, D.; Goldstein, K.; Wen-Kai Weng ; Shizuru, J.; Horning, S.; Negrin, R. | Blood | | | |
| 2017 | Consolidative CD8(+) Memory T-Cell Donor Lymphocyte Infusion Augments Donor Chimerism with a Low Risk of Gvhd Following Matched Related Donor Hematopoietic Cell Transplantation | Spinner, M. A.; Muffly, L. S.; Arai, S.; Johnston, L.; Meyer, E. H.; Miklos, D. B.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Strober, S.; Lowsky, R. | Blood | | | |
| 2015 | Donor-Derived CIK Cell Infusion As Consolidative Therapy after Non-Myeloablative Allogeneic Transplant in Patients with Myeloid Neoplasms | Narayan, R.; Benjamin, J.; Laport, G.; Tian, L.; Tate, K.; Elder, L.; Galvez, L.; Armstrong, R.; Sheehan, K.; Lowsky, R.; Arai, S.; Johnston, L.; Miklos, D.; Muffly, L. S.; Rezvani, A. R.; Shizuru, J.; Wen-Kai Weng ; Strober, S.; Negrin, R.; Meyer, E. | Blood | | | |
| 2009 | A Dose Escalation Trial of Imatinib for Steroid Dependent Chronic Graft-Versus-Host Disease with Anti-PDGFRA Antibody Analysis | Chen, G. L.; Arai, S.; Flowers, M. E. D.; Otani, J.; Cheng, E. C.; McMillan, A.; Wen-Kai Weng ; Shizuru, J.; Johnston, L.; Miklos, D. | Blood | | | |
| 2013 | Early Infusion Of Donor-Derived CIK Cells As Consolidative Immunotherapy Following Non-Myeloablative Allogeneic Transplantation: Safety and Feasibility | Benjamin, J.; Laport, G. G.; Tate, K.; Galvez, L.; Armstrong, R.; Sheehan, K.; Arai, S.; Lowsky, R.; Johnston, L.; Miklos, D. B.; Shizuru, J.; Wen-Kai Weng ; Negrin, R. | Blood | | | |
| 2018 | Elevated Axicabtagene Ciloleucel (CAR-19) Expansion By Immunophenotyping Is Associated with Toxicity in Diffuse Large B-Cell Lymphoma | Spiegel, J. Y.; Sahaf, B.; Hossain, N.; Frank, M. J.; Claire, G.; Abramian, M.; Latchford, T.; Villa, B.; Cancilla, J.; Oak, J.; Natkunam, Y.; Long, S. R.; Arai, S.; Johnston, L. J.; Lowsky, R.; Meyer, E. H.; Muffly, L. S.; Negrin, R. S.; Rezvani, A. R.; Shizuru, J. A.; Wen-Kai Weng ; Kong, K. A.; Mackall, C. L.; Miklos, D. B. | Blood | | | |
| 2014 | European LeukemiaNet classification intermediate risk-1 cohort is associated with poor outcomes in adults with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation | Medeiros, B. C.; Tian, L.; Robenson, S.; Laport, G. G.; Johnston, L. J.; Shizuru, J. A.; Miklos, D. B.; Arai, S.; Benjamin, J. E.; Wen-Kai Weng ; Negrin, R. S.; Lowsky, R. | Blood Cancer Journal | | | |
| 2012 | Graft-versus-lymphoma effect after non-myeloablative allogeneic transplant induces molecular remission assessed by high-throughput sequencing of T cell receptor in patients with advanced stage mycosis fungoides (MF) and Sezary syndrome (SS) | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H. | Journal of Investigative Dermatology | | | |
| 2011 | Graft-Versus-Lymphoma Effect After Non-Myeloablative Allogeneic Transplant Induces Molecular Remission Assessed by High-Throughput Sequencing of T Cell Receptor in Patients with Advanced Stage Mycosis Fungoides and Sezary Syndrome | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Sutherland, K.; Hoppe, R. T.; Kim, Y. H. | Blood | | | |
| 2018 | Hedgehog Pathway Inhibitor for Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD) | Gupta, R.; Albabtain, A.; Arai, S.; Kwong, B.; Wen-Kai Weng | Blood | | | |
| 2017 | HLA-mismatched unrelated donor transplantation using TLI-ATG conditioning has a low risk of GVHD and potent antitumor activity | Spinner, M. A.; Fernandez-Vina, M.; Creary, L. E.; Quinn, O.; Elder, L.; Arai, S.; Johnston, L. J.; Meyer, E. H.; Miklos, D. B.; Muffly, L. S.; Negrin, R. S.; Shizuru, J. A.; Wen-Kai Weng ; Laport, G. G.; Strober, S.; Lowsky, R.; Rezvani, A. R. | Blood Advances | | | |
| 2018 | Infusion of donor-derived CD8(+) memory T cells for relapse following allogeneic hematopoietic cell transplantation | Muffly, L.; Sheehan, K.; Armstrong, R.; Jensen, K.; Tate, K.; Rezvani, A. R.; Miklos, D.; Arai, S.; Shizuru, J.; Johnston, L.; Meyer, E.; Wen-Kai Weng ; Laport, G. G.; Negrin, R. S.; Strober, S.; Lowsky, R. | Blood Advances | | | |
| 2016 | Long-Term Outcomes of AML Patients Using Total Lymphoid Irradiation with Anti-Thymocyte Globulin | Nakasone, H.; Miklos, D. B.; Meyer, E.; Rezvani, A.; Muffly, L.; Wen-Kai Weng ; Arai, S.; Johnston, L.; Laport, G. G.; Shizuru, J. A.; Negrin, R.; Strober, S.; Lowsky, R. | Biology of Blood and Marrow Transplantation | | | |
| 2016 | Long-term outcomes of high-dose melphalan and carmustine followed by autologous hematopoietic cell transplantation for multiple myeloma | Neppalli, A. K.; Shizuru, J.; Johnston, L. J.; Muffly, L. S.; Wen-Kai Weng ; Negrin, R.; Meyer, E.; Laport, G.; Lowsky, R.; Arai, S.; Miklos, D. B.; Rezvani, A. R. | Journal of Clinical Oncology | | | |
| 2013 | Minimal Residual Disease Monitoring with High-Throughput Sequencing of T Cell Receptors in Cutaneous T Cell Lymphoma | Wen-Kai Weng ; Armstrong, R.; Arai, S.; Desmarais, C.; Hoppe, R.; Kim, Y. H. | Science Translational Medicine | | | |
